IACTA Pharmaceuticals is an Irvine, California-based ophthalmic company developing a portfolio of novel assets in large ocular markets, initially focusing on ocular pain and dry eye disease.

We are addressing a significant gap in the pharmaceutical pipeline by partnering with research firms and leveraging innovative technologies like nano-encapsulation to deliver targeted treatments to the eye.

Driven by a dedicated team of experienced ophthalmology and pharmaceutical professionals, including former executives from leading eye care companies, IACTA is committed to accelerating innovation and bringing impactful solutions to patients worldwide.

Our approach combines cutting-edge R&D with strategic partnerships, positioning us at the forefront of ophthalmic product development and addressing significant unmet medical needs in the $10+ billion ocular pain market.

IC 265 | IACTA Pharmaceuticals

Product description

IACTA Pharmaceuticals Irvine, United States (US)

Price: N/A

IACTA Pharmaceuticals
Irvine, United States (US)